PF-2771
PF-2771 is a potent and selective centromere protein E (CENP-E) inhibitor, inhibiting CENP-E motor activity with an IC50 of 16.1 nM; PF-2771 is used as an anticancer agent.
Product Specifications
CAS Number
2070009-55-9
UNSPSC
12352005
Target
Kinesin
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Cytoskeleton
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/PF-2771.html
Concentration
10mM
Purity
99.66
Solubility
DMSO : ≥ 32 mg/mL
Smiles
ClC1=CC(C(N[C@@H](CC2=CC=C(C3=CN(C)C(C(C)=O)=N3)C=C2)CNC(CN(C)C)=O)=O)=CC=C1OC(C)C
Molecular Formula
C29H36ClN5O4
Molecular Weight
554.08
References & Citations
[1]Kung PP, et al. Chemogenetic evaluation of the mitotic kinesin CENP-E reveals a critical role in triple-negative breast cancer. Mol Cancer Ther. 2014 Aug;13 (8) :2104-15.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Kinesin-7/CENP-E
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
E-CL-R0190-01 24 Tests
Rat CXCR3 (CXC-Chemokine Receptor 3) CLIA Kit
Sign In for Pricing
View Details E-CL-R0190-02 48 Tests
Rat CXCR3 (CXC-Chemokine Receptor 3) CLIA Kit
Sign In for Pricing
View Details E-CL-R0190-03 96 Tests
Rat CXCR3 (CXC-Chemokine Receptor 3) CLIA Kit
Sign In for Pricing
View Details